(Q43599299)

25 November 2017

0 references

1 reference

title

Cardiac enzyme elevations after percutaneous coronary intervention: myonecrosis, the coronary microcirculation and mortality (English)

1 reference

25 November 2017

Harrington RA

1

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

Journal of the American College of Cardiology

25 November 2017

published in

1 reference

25 November 2017

volume

35

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

1142-1144

1 reference

Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

Prognostic implication of creatine kinase elevation following elective coronary artery interventions.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

Acute and long-term cost implications of coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

Myonecrosis after revascularization procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

Coronary-Artery Stents — Gauging, Gorging, and Gouging

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

Glycoprotein IIb/IIIa integrin blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900524-6

7 January 2021

10.1016/S0735-1097(00)00524-6

Identifiers

DOI

1 reference

25 November 2017

1 reference